Hensley Mark Earl Insider Trades

Insider Trading History

Track insider trading activity for Hensley Mark Earl. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $181k 375,000 shares
Last Trade
May 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$164k 125,000 shares
$1.31
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $66.1k 136,770 shares
Last Trade
May 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$164k 125,000 shares
$1.31
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $85.4k 176,545 shares
Last Trade
Apr 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.1k 11,770 shares
$1.20
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $5.69k 11,770 shares
Last Trade
Apr 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.1k 11,770 shares
$1.20
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $91.1k 188,315 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$497k 376,629 shares
$1.32
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Chief Operating Officer
Holding Value $242k 500,000 shares
Last Trade
May 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.21M 500,000 shares
$2.42
$0.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up